Estrogen Receptor α Signaling in Salivary Gland Tumors: Lessons Learned from Breast Carcinoma
Keywords:
Estrogen receptors α, Salivary gland tumors, breast carcinoma, neoadjuvant therapyAbstract
Introduction: Successful antihormonal therapy in breast cancers has convinced researchers to find hormonal targets in salivary gland tumors (SGTs) due to histological and morphological similarities between the two types of glands and their tumors. The aim of this study was to determine expression of estrogen receptor (ER) α in SGTs in our region to see if the same treatment regimen may be followed in SGTs with some modifications if needed according to breast tumors.
Materials and Methods: This retrospective analysis was carried out on 57 already diagnosed cases of SGTs. Cases were recruited from histopathology labs of Ayub Medical College, Peshawar Medical College and City laboratory Peshawar. All cases were examined immunohistochemically for ER α expression. Assessment was done by Allred scoring.
Results: Among 57 cases of SGTs, positive hormonal expression was found in 54.4% of cases while 45.6% of cases were found negative.
Conclusion: This study concluded that ER α can be considered as an attractive target for antihormonal therapy in the subset of SGTs expressing them in variable proportions.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Nasiha Bashir; Fatima Iqbal, Sajjad Ahmad, Syeda Tabreek Motahir, Samrina Mohammad, Tehmina Nausheen
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
